NCT01059331

Postoperative Analgesia After Laparoscopic Living Donor Nephrectomy

Perioperative Administration of Pregabalin in Laparoscopic Living Donor Nephrectomy (L-LDN) - an Adjuvance to Peroral Analgetic Treatment - a Randomized Controlled Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to investigate if perioperative administration of pregabalin vil reduce postoperative pain and the postoperative need for intravenous opioids compared with todays standard treatment which consist of paracetamol, corticoids and ketobemidone. In addition potential sideeffects as sedation and effect on cognitive function will be recorded.

Conditions

• Living Donors

Interventions

Type	Name	Description
DRUG	Pregabalin	150 mg x 2 daily for 2 days
DRUG	Sugar pill	1 tablet x 2 daily, for 2 days

Timeline

• Start date: 2010-02-01
• Primary completion: 2011-10-01
• Completion: 2012-12-01
• First posted: 2010-01-29
• Last updated: 2014-03-21

Locations

1 site across 1 country: Norway